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Background: Foot-and-mouth disease virus (FMDV) is an extremely infectious 
and antigenically diverse picornavirus of cloven-hoofed animals. Strains of the 
A22 subtype have been reported to change antigenically when adapted 
to different growth conditions. To investigate the structural basis of this 
phenomenon we have determined the structures of two variants of 
an A22 virus. 
Resu.lts: The structures of monolayer- and suspension-cell-adapted A22 FMDV 
have been determined by X-ray crystallography. Picornaviruses comprise four 
capsid proteins, VP1-4. The major antigenic loop of the capsid protein VP1 is 
flexible in both variants of the A22 subtype but its overall disposition is distinct 
from that observed in other FMDV serotypes (0 and C). A detailed structural 
comparison between A22 FMDV and a type 0 virus suggests that different 
conformations in a portion of the major antigenic loop of VP1 (the GH loop, 
which is also central to receptor attachment) result in distinct folds of the 
adjacent VP3 GH loop. Also, a single mutation (Glu82~Gly) on the surface of 
VP2 in the suspension-cell-adapted virus appears to perturb the structure of the 
VP1 GH loop. 
Conclusions: The GH loop of VP1 is flexible in three serotype~ of FMDV, 
suggesting that flexibility is important in both antigenic variability and structural 
communication with other regions of the virus capsid. Our results illustrate two 
instances of the propagation of structural perturbations across the virion surface: 
the change in the VP3 GH loop caused by the VP1 GH loop and the 
Glu82~Gly change in VP2 which we believe perturbs the GH loop of VP1 . In 
the latter case, the amplification of the sequence changes leads to differences, 
between the monolayer- and suspension-cell-adapted viruses, in host-cell 
interactions and antigenicity. 
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Introduction 
The picornavirus foot-and-mouth disease virus (FMDV) 
was the first animal virus for which a plurality of serotypes 
was observed [1]. Seven serotypes (0, A, C, Asia 1 and 
SATI-3) and numerous subtypes of FMDV have now 
been characterized. Antigenic variation occurs across a 
spectrum, from serotypic variation, where the differences 
are sufficient to prevent the immune system providing 
cross protection, to variation in a very small number of 
amino acids which only affects the binding of a subset of 
antibodies directed against the virus. 
X-ray crystallography has been used to investigate the struc-
tural basis of antigenic variation in vertebrate viruses, in par-
ticular the membrane proteins of influenza virus [2-5], and 
of whole picornaviruses [6-13]. Picornaviruses possess an 
icosahedrally symmetric shell formed by 60 copies of each 
capsid protein VPI-4. They have a common core structure 
for their major capsid proteins (VPI-3) consisting of an 
eight-stranded ~-barrel, the strands being labelled alpha-
betically from B to I (Fig. 1). Structural comparisons 
between serotypes have been made for poliovirus [8], 
human rhinovirus [9,11], and FMDV [12]. These studies, 
which include the analyses of the 0 and C serotypes of 
FMDV, have begun to delineate the structural basis of anti-
genic variation and have shown that for any given picor-
navirus the surface loops and termini vary between 
serotypes. However, only one study of more closely related 
viruses has been reported [13]. Here we compare the struc-
tures of two laboratory-grown strains of type A22 Iraq 24/64 
F:vlDV which display significant antigenic variation but 
differ by only two amino-acid substitutions [14]. 
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Figure 1 
Although immune selection pressure is commonly cited 
as a primary cause of antigenic change, other factors , 
such as viral persistence and adaptation to new cell types, 
may also be important in influencing antigenicity [151 -
These factors have been observed for a number of differ-
ent viruses: adaptation of influenza to culture in ovo 
[16-18], or of HIV [191 and FMDV [14,20,211 to in vitro 
tissue culture, has been observed to result in antigenic 
changes. T his gives cause for concern about the study of 
antigenic properties of laboratory-grown viruses_ Con-
versely, antibody mediated selection pressure can affect 
cell tropism in influenza virus [22,231 . In the case of 
FMDV, the link between antigenic change and tissue 
culture adaptation arises because the Arg-Gly-Asp motif 
in the GH loop of VP1, which is crucial to receptor 
binding [21 ,24,25], is flanked by variable sequences 
which constitute a very important antigenic site on the 
viral surface [26-291. 
Structure of A'2'2 FMDV and comparison with 
types 0 1 BFS and C-SSc 1 . (a) Cn trace of a 
protomeric subunit of monolayer-cell-adapted 
A'2'2 FMDV within the context of a pentamer. 
The protomer is highlighted with thick lines 
and colour-coded with VP1 in blue, VP'2 in 
green and VP3 in red. The other protomers of 
the pentamer are depicted with thinner lines 
and coloured with VP1 in cyan, VP'2 in olive 
green and VP3 in orange. The icosahedral 
fivefold and threefold symmetry axes are 
indicated. Note that the N-terminal portion of 
the VP1 GH loop from one protomer lies 
adjacent to the VP3 GH loop of a fivefold-
related protomer and that the C terminus of 
VP1 contacts the opposite side of the GH 
loop of VP3. (b) A comparison of the GH 
loops of VP1 and VP3 for FMDV types A'2'2, 
0 1 BFS and C-SSc 1 . The image depicts the 
VP1 GH loop from one protomer and the VP3 
GH loop from the fivefold-related protomer 
within a pentamer. FMDV A'2'2 proteins are 
shown with thick lines and colour-coded with 
VP1 in blue, VP'2 in green and VP3 in red. The 
corresponding proteins are shown in orange 
for 0 1 BFS and pink for C-SSc1. The N- and 
C-terminal portions of the GH loop of VP1 are 
labelled 'N' and 'c' respectively. 'C-term.' 
indicates the C terminus of VP1 from a 
fivefold-related protomer. 
The two A22 FMDVs used in this study [141 were 
selected by passaging in different tissue culture conditions 
The first, adapted for growth in monolayers of BHK-21 
cells, is antigenically similar to the original isolate and iso-
lates from subsequent outbreaks of the disease in the same 
geographical area [141 . Immunity induced by this strain 
was broadly effective against a wide range of related strains 
and so it was considered to be a good candidate vaccine 
virus [301 - However, adaptation of this monolayer-grown 
virus to suspension BHK cell culture repeatedly resulted 
in a variant which displayed significant differences in cell 
binding, antigenicity and other phenotypic properties 
[14,311 _ Surprisingly, the amino-acid sequence in the VP1 
GH loop is identical in the two viruses. The three muta-
tions found in the suspension-cell-adapted virus are all 
confined to VP2; the . two surface-exposed amino-acid 
changes are hypothc::sized to alter the virus phenotype by 
virtue of their effect on the GH loop ofVPl [141. 
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To investigate the structural consequences of tissue 
culture adaptation, the structures of the monolayer- and 
suspension-cell-adapted A22 FMOVs have been deter-
mined at 3.0 A and 2.4 A resolution, respectively, by X-ray 
crystallography. The resulting atomic models were refined 
to the respective R factors of 17.6% and 17.9%. In both 
viruses, the GH loop of VP1 is flexible but its overall dis-
position can be distinguished from conformations 
observed in ° and C serotypes of FMOV [10,12]. We 
present structural evidence which suggests that inter-
action of the GH loop with other parts of the viral surface 
can amplify the structural and antigenic effects of 
sequence variation. Comparison of the monolayer- and 
suspension-cell-adapted viruses reveals that one of the 
changes (Glu82 to Gly) on the surface of VP2 perturbs the 
GH loop of VP1, in what appears to be a further example 
of amplification, and is the principal determinant of the 
phenotypic alteration. 
Results 
Structure of monolayer-cell-adapted A22 FMDV 
Comparison with other FMDV structures 
The structure of FMOV A22 Iraq (Fig. 1a) is very similar 
to that reported for type ° FMOV [10] and type C FMOV 
[12]. As expected, the main structural differences between 
FMOV A22 and the ° and C viruses are found in the 
loops and C termini of VPl-3 that decorate the external 
surface of the virus. For the cores of the capsid proteins, 
the root mean square (rms) deviation of Ca positions of 
the type A virus is only 0.3 A relative to °1 BFS and 0.4 A 
relative to C-S8cl. However, the Ca positions within the 
surface loops are observed to vary by as much as 12 A 
between the three virus serotypes. This is similar to 
the values found in serotype comparisons of other 
picornaviruses such as poliovirus [8] and human rhinovirus 
[9,11], even though the surface loops in FMOV are 
generally shorter [32]. 
A comprehensive comparison of the structures of the 
various aphthoviruses that we have analyzed, and a full 
discussion of the structural basis of antigenic variation for 
the aphthoviruses, will be presented elsewhere. Here we 
will refer to these other viral serotypes only in relation to 
features which are, so far, peculiar to A22. 
The GH loop of VP1 
The longest surface loop in A22 FMOV, the GH loop of 
VP1, does not feature in the electron-density map, pre-
sumably because of disordering, therefore residues 
137-155, inclusive, are absent from the model. The appar-
ent conservation of flexibility within this region in several 
FMOV structures [10,12] reinforces the view that confor-
mational variability is an important attribute of the viral 
surface. However, we can infer that, as well as sequence 
changes, there are differences in the overall disposition of 
this loop between the A and ° serotypes (Fig. 1b). The 
residues, at the beginning of the GH loop of VP1 in A22 
FMOV (130-136), which are visible in the electron-
density map adopt a very different conformation from the 
visible residues at the beginning of the loop in FMOV 
0IBFS (130-134) [10]. This is likely to be caused by the 
absence, in type A, of a disulphide bridge which, in 
0IBFS, pins Cys134 of the VP1 GH loop to Cys130 in 
VP2. Neither of these cysteines occurs in FMOV A22 and 
the beginning of the GH loop is free to lie in the opposite 
direction, pointing away from VP2 and towards VP3 
(Fig. 1 b). (Reduction of the disulphide bond in dithiothre-
itol (OTT)-treated 0IBFS allows residues 130-136 ofVP1 
to adopt a very similar conformation to that observed in 
A22 [33]; see below.) Similarly, there is no disulphide bond 
at the start of the GH loop in C-S8cl. However, in this 
case the density for the loop disappears beyond Gly132 
[12] although thc apparent difference between this and 
the GH loop of A22 FMDV may be due to the high tem-
perature factors of the C-S8c1 structure. At the C-terminal 
end of the loop, where the electron density is again visible 
for A22, the differences between the three serotypes are 
less significant (Fig. 1 b). Nevertheless, the divergent paths 
evident at the beginning of the loop strongly suggest that 
between A and ° type viruses there are major conforma-
tional alterations in the whole loop that are likely to 
exceed the maximum observed difference of 12 A. 
Intwaction between the GH loops of VP1 and VP3 
Adjacent to the VP1 GH loop on the virus surface is the 
VP3 GH loop from a fivefold-related protomer. Strikingly, 
in FMOV A22 the fold of the GH loop of VP3 (residues 
173-182) is considerably altered from the predominant 
conformation in 0IBFS [10], although there are no 
sequence differences between the two viruses in this 
region (Figs 1 b,2). The average shift in Ca position is 
4.5 A. The structural difference between the VP3 GH 
loops in these two viruses appears to be due to differences 
in conformation of the adjacent VP1 GH loops. 
This interpretation is supported by the observation that 
treatment of crystals of °1 BFS with 10 mM OTT reduced 
the disulphide bond between Cys134, at the start of the 
VP1 GH loop, and Cys130 in VP2, and resulted in the loop 
adopting a stable conformation that was clearly observed 
in the electron-density map [33]. In this OTT-treated 
structure the VP1 GH loop lies predominantly over the 
surface ofVP2; residues 130-136 ofVP1 approach the GH 
loop of VP3 in a fivefold-related protomer and the GH 
loop of VP3 was observed to be refolded. This refolding 
was presumably due to the radical shift in the position of 
the GH loop of VP1, as it does not contain cysteines that 
might be affected by the presence of OTT (Fig. 2). 
In A22 FMOV, residues 130-136, in the GH loop of VP1, 
and the adjacent GH loop of VP3 adopt conforma-
tions that are almost identical to those observed in 
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Figure 2 
OTT-treated 0IBFS FMOV (Fig. 2b). This finding sug-
gests that the structural factors which determine the shift 
of the VP3 GH loop upon the reduction of the VP1-VP2 
disulphide in °1 BFS also determine the structural differ-
ence in this region between native °1 BFS and A22. A 
factor allowing the shift is the absence of a disulphide 
bond fixing the start of the VPl GH loop to VP2 and the 
burial of Tyr136 of VPl is likely to be a significant driving 
force. In A22, the side chain of this tyrosine is contained 
within an amphiphilic pocket formed by amino acids from 
VP2 and VP3. Residues 176-178 of VP3, which line one 
side of the pocket, are contained within the GH loop of 
VP3. In OTT-treated 0IBFS, Tyr136 of VPl is slightly 
more buried, possibl y due to the presence of a valine 
rather than a lysine at position 173 in VP2, which, between 
the two viruses, is the only sequence difference in the 
pocket. In A22 the side chain of Lys 173 sterically prevents 
Tyr136 descending further into the pocket (Fig. 2b). 
Further differences between the VPl GH loops and other 
surface features of the two viruses may also be involved; 
for example, residues 190-200 in the C-terminal portion of 
VP1, which vary between serotypes, also pack against the 
GH loop ofVP3 (Fig. 1). In A22 FMOV the VP3 GH loop 
is quite mobile, as indicated by the high B factors for this 
portion of the model (the average B factor for the main-
chain atoms of residues 173-182 is 54.9 AZ). In fact an 
F o-F c omit map for A22 suggests that the GH loop of VP3 
may also adopt a conformation similar to that observed in 
Conformation of the VPl GH loop affects the 
VP3 GH loop conformation in a neighbouring 
protomer. (a),(b) A detailed comparison 
between A22 FMOV and native (a) and on-
treated (b) O,BFS FMOV; the diagram 
compares the interactions of the GH loops of 
VPl and VP3 . For A22, residues 130-136 of 
VPl are shown in blue, residues 170-175 of 
VP2 in green and residues 1 72-1 81 of VP3 in 
red. The corresponding portions of native and 
On-treated O,BFS are shown in cyan, yellow 
and orange, respectively. For clarity only main-
chain atoms are depicted although side chains 
are included for Tyr136 of VP1, Lys172 of VP2 
and Thrl 78 of VP3 in A22, and for the 
corresponding residues in 0, BFS (VP1, Tyr136; 
VP2, Vall 73; VP3, Thr177). Tyr136 of VPl is 
not visible in native 0, BFS as the electron 
density terminates beyond position 134 in VP1. 
(c) A stereo view of an Fo -Fe omit map for the 
VP3 GH loop of the parent A22 virus (residues 
170-185). The atom trace is shown in red with 
the electron density contoured at twice the 
sigma level in green and at the sigma level in 
light brown. The density suggesting that this 
loop may also adopt a conformation similar to 
that observed in untreated O,BFS, though at 
very much lower occupancy, is the fragmented 
brown density looping round to the right of 
Tyr170 and identified by a white asterisk. 
untreated 0IBFS, although at very much lower occupancy 
(Fig. 2c). The conformational switching of this region in 
A22 may well be linked to movements of the flexible VPl 
GH loop (the average B factor for the main-chain atoms of 
residues 130-136 is 47.1 AZ). 
Given this evidence that the GH loops of VPl and VP3 
interact, the observation that the dominant conformation 
of the GH loop of VP3 in C-S8cl FMOV is similar to that 
in the native °1 BFS but different to that in type A22 
(Fig. 2b) suggests that there are differences between A22 
and C-S8cl in the disposition of the VPl GH loops. 
Structure of the suspension-cell-adapted A22 variant 
The structure described above is for a virus which was 
plaque purified from a stock that had been passaged 13 
times in BHK-21 cell monolayers. The suspension-cell-
adapted variant of FMOV A22 was generated by three 
passages of the monolayer-cell-adapted virus stock in 
BHK-21 suspension cells; it was also plaque purified [14]. 
The variant displays cell-binding and antigenic properties 
distinct from those of the parental monolayer-cell-adapted 
A22 virus [14]. It was originally anticipated that the variant 
would contain mutations in the GH loop of VP1, which 
contains the primary determinant for interaction with the 
cellular receptor [21,24,25] and is a prominent antigenic 
feature on the viral surface [10,34-36]. However, the 
sequence reported for the variant [14] contained only 
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Figure 3 
Fovar-F/ar difference density superimposed 
on the model of monolayer-adapted A22 
FMDV illustrating side-chain differences 
between monolayer- and suspension-cell-
adapted A22 FMDV. (a) The negative density 
contours shown in orange indicate 
replacement, at position 82 in VP2, of 
glutamate by glycine in the suspension-cell-
adapted variant. However, there is no 
difference density to suggest the replacement 
in the variant of lysine by threonine at position 
88 in VP2. (b) Positive density contours in 
green confirm the replacement of histidine at 
position 207 in VP2 by tyrosine in the variant. 
Beneath this residue, positive density 
indicates increased ordering of Glu40, Asp41 
and, to a lesser extent, His42 of VP2 in the 
suspension-cell-adapted virus. 
three mutations, all of them located in VP2 although lying 
in close proximity to the VPl GH loop_ It has been specu-
lated that one or two of these mutations might affect the 
VPl GH loop structure and thus account for the altered 
phenotype [31]. 
The difference electron density map F ovar-F opar, calcu-
lated using phases from averaging the parental map, bears 
clear evidence for two of the three reported mutations in 
VP2. There is a negative density feature at the location of 
the side chain of Glu82 consistent with the substitution of 
a glycine in the variant (Fig. 3a). A peak of positive 
density confirmed the replacement of His207 by a tyro-
sine residue (Fig. 3b). However, there was no density to 
support the mutation of Lys88 to threonine (Fig. 3a) and a 
2F 0 var_F /ar map clearly indicated that lysine remained at 
position 88. This was confirmed by sequencing cDNA 
derived from the viral RNA. Despite this apparent rever-
sion, the variant strain used in this study retained the dis-
tinctive ability to infect suspension cells as described by 
Bolwell and colleagues (data not shown) [14]. 
The 2Fova'-F/ar map (calculated with model phases after 
refinement and IS-fold averaged) contains other interest-
ing features. Most notable is the presence of additional 
density indicative of increased order in portions of the 
VPl GH loop. In the parent virus structure, density corre-
sponding to residues 137 to 155, inclusive, was absent 
from the map. In the variant map, the electron density 
permitted inclusion of Ser137 at the start of the GH loop. 
An F 0 var_F /ar omit map calculated with a phasing model 
lacking residues 130-137 of VPl and residues 170-185 of 
the adjacent VP3 GH loop confirmed the presence of 
Ser137 (Fig. 4). There is also additional density attached 
to the carbonyl oxygen of Leu66 in VP2. Close to this 
leucine the side-chain density of Glu79 in VP2 is signifi-
c'antly stronger indicating greater ordering of this residue 
in the variant than in the parental structure. The side-
chain of Lys88 in VP2 also appears more ordered, as does 
the Glu218 at the C terminus of the twofold-related VP2, 
which lies only 3.5 A from Lys88. Although these indica-
tions do not permit construction of a model, they suggest 
that portions of the VPl GH loop may be more ordered in 
the variant and more closely associated with the surface of 
VP2, in a conformation somewhat akin to the loop struc-
ture in OTT-treated OjBFS [33]. Conversely, there is no 
density to support inclusion of Ala156 at the C-terminal 
portion of the VPl GH loop, suggesting that this minor 
part of the G H loop may be more disordered in the variant 
than in the parent. 
The two sets of diffraction data are of differing quality, 
completeness and resolution, with the variant data being 
sparse at higher resolution (Table 1). However, the fact 
that some residues are observed to be more ordered in one 
structure and some more ordered in the other suggests 
that these features are genuinely significant. Moreover, 
when the 2Fo-Fc maps for parent and variant are adjusted 
to give coincident contours for the side chains of buried 
residues the additional features exposed on the surface of 
VP2 are still evident, again suggesting that they are real. 
Finally, we have independently determined the structure 
of the A22 empty capsid and observe no such differences 
in the VPl GH loop structure (unpublished results). 
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Figure 4 
An Fo-Fe omit map calculated for the suspension-cell-adapted variant 
of A22 FMDV. Residues 130-137 in the GH loop of VPl and 
170-183 in the GH loop of VP3 were omitted from the model used to 
c alculate the phases. The resulting density confirms the model for 
residue 137 in VP1. Gln157 is the first residue visible in a 2Fo-Fe map 
at the C-terminal portion of the VPl GH loop. 
The structural differences in the VPl GH loop, between 
the parent and variant, are relatively minor and the appar-
ently greater stability of the loop in the variant is slight. 
For both viruses the VPl GH loops are very flexible. Anti-
genic differences between the two viruses in this region 
may simply result from the expression of different sets of 
loop conformations. 
Curiously, the BC loop of VP3 in the variant shows a clear 
difference from the parent. This loop, which is the most 
surface exposed loop on VP3 (located at the bottom right 
of the protomer shown in Fig. 5), appears to adopt two con-
form ations in the variant, one of which is similar to the con-
form ation found in the parent (and in C-S8c1); the other 
(which is better occupied and therefore included in the 
model) is similar to the conformation found in 0IBFS [10]. 
This difference is hard to explain as there are no reported 
sequence differences between the parent and variant in 
the BC loop or adjacent portions of the structure. The 
variant was crystallized at a slightly lower ionic strength 
and in the presence of l,4-dioxane, either of which may 
account for variation in the VP3 BC loop, but the packing 
interactions in the crystals of the wild-type and variant 
viruses were identical and structures of FMDV 01 BFS in 
ammonium sulphate and PEG were indistinguishable from 
each other (unpublished results). Alternatively the differ-
ences in the conformations of the VPl GH loop in the 
monolayer- and suspension-cell-adapted viruses may affect 
Table 1 
Data processing and model refinement statistics. 
Data processing 
Number of films 
Monolayer-cell-
adapted virus 
22 
Number of images 64 
Total reflections 483707 
Independent reflections 251 190 
Completeness (outer shell) [%) 61.7 (21.1) 
Rmerge * (outer shell) [%) 
CA/ 
RAv* 
Refinement 
Range of spacings (A) 
Total non-hydrogen atoms 
Solvent sites 
Rmodel§ (all data) 
~bonds* (A) 
~.ngles ** (0) 
~B bondstt (A2) 
~B angles** (A2) 
Average 8 (A2) 
17.9 (35.2) 
0.976 
21 .9% 
25-3 
5200 
310 
17.6 
0.015 
1.91 
2.15 
3.64 
17.0 
*Rmerge=[~ fl(Ih -Ih;)I)/[~ f1h;) x 1 00 
~ - -
h (Fobs-IFhobsl)(F.v-IFh.vi) tc .
AV- [~ (Fobs -IFh.Obsl)2.~ (F.v- I Fh .• ))2) 'h 
* ~ 1(IFh.obsHFh .• )) 1 
RAV- ~ xl00 
h I Fh.obsl 
§ ~ 1(IFh.obsHFh.calel) 1 
Rmoder ~ x 1 00 
h I Fh.obsi 
Suspension-cell-
adapted virus 
o 
16 
120353 
110781 
14.1 (3.5) 
9.6 (27.5) 
17-2.4 
5202 
243 
17.9 
0.015 
1.94 
2.29 
3.66 
17.6 
*Rmsd from ideal covalent bond lengths. **Rmsd from ideal covalent 
bond angles. ttRmsd of 8 factors for the bond restraints. **Rmsd of 8 
factors for the angle restraints. For the monolayer-cell-adapted virus, 
some 88% of the residues lie in the most favoured region of the 
Ramachandran plot and none in disallowed regions. For the 
suspension·cell-adapted virus, some 89% of the residues lie in. the 
most favoured region of the Ramachandran plot and none are in 
disallowed regions. 
the VP3 BC loop structure; the length of the flexible 
portion of the VPl GH loop is indeed sufficient to allow it 
to contact a threefold-related BC loop of VP3. 
One other unexpected difference between variant and 
parent is the relative ordering of residues 40-42 in VP2 of 
the variant. This segment is located at the interior face of 
the capsid, immediately adjacent to the viral RNA. The 
side chain of Glu40 lies only 3.9 A from residue 207 in VP2 
which is mutated from a histidine to a tyrosine in the sus-
pension-cell-adapted variant (Fig. 3b). It may be that the 
interaction with the surrounding RNA is affected in the 
variant, constraining residues 40-42. 
Discussion 
Novel features of A22 FMDV 
The exposed, flexible GH loop ofVPl of FMDV contains 
a strictly conserved motif (Arg-Gly-Asp) which is primarily 
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responsible for binding the virus to its cellular receptor 
[21,24,25] . No density was observed for most of the VPl 
GH loop of type A22 FMDV consistent with the struc-
tures of type ° and C FMDV [10,12] . Nevertheless, dif-
ferences in the structures and orientations of the visible 
portions at the beginning and end of the loop indicate that 
serotype-specific dispositions are adopted in type 0, C 
and A viruses (Fig. 1 b). Distinct sets of loop conformations 
may characterize each serotype. Recent studies shed some 
light on the nature of these differences. The structure of 
an antibody Fab fragment bound to a peptide correspond-
ing to the VPl GH loop of a type C FMDV showed the 
internal structure of the loop to be strikingly similar to that 
in the OTT-treated type 01BFS virus (in which the whole 
loop is clearly visible), despite significant sequence varia-
tion between the two serotypes [37]. Another investiga-
tion with OTT-treated variants of type 01 FMDV found 
that mutations within the loop had no observable effect on 
the main-chain structure and suggested that the loop may 
be able to move in the native virus as a hinged unit that 
has significant internal stability [13]. The diverse confor-
mations of this loop noted above for 0, A and C serotypes 
may therefore be due, in part, to differences in the 
preferred orientation of this unit. 
In contrast, although the amino-acid sequences of the VP3 
GH loop of A22 and 01BFS FMDV are identical , this loop 
adopts distinct folds in the two viruses (Fig. 2), apparently 
due to different conformations of the VPl GH loops in 
these two serotypes. This loop is an antigenic feature of 
the virus [29], therefore the observed conformational 
changes appear to amplify the antigenic impact of 
sequence and structural variation within the GH loop of 
VPl. Further instances have been reponed in which inter-
actions of the GH loop of VPl with other parts of the viral 
surface leads to potential amplification of antigenic varia-
tion (Fig. 5). Variants of 01 BFS FMDV, raised under the 
selective pressure of a monoclonal antibody which recog-
nised part of the VPl GH loop, contained mutations, not 
in the GH loop, but in the BC loop of VPl [38], which is 
itself an antigenic site [28]. Differences in the structure of 
the VPl GH loop of these variants were indeed observed , 
presumably due to the side-chain substitutions in the BC 
loop [38]. In another study, a mutation in VP2 (position 
80) of FMDV AlO Holland was found to abrogate recogni-
tion by some monoclonal antibodies directed against the 
GH loop of VPl [27]. Finally, in the viruses which are the 
subject of this paper, a mutation in VP2, generated by 
adaptation of the virus to suspension-cell culture, leads to 
altered antigenicity of the GH loop of VPl [31,39]. 
Clearly, point mutations on the virus surface can have a 
very significant impact on the VPl GH loop structure. We 
now find that a reciprocal effect also occurs, the VP I G H 
loop affecting the conformation and antigenicity of an 
adjoining feature, the GH loop of VP3. The flexibility of 
the GH loop of VPl may have two roles in promoting 
Figure 5 
Residues which are reported to influence, or be influenced by, the GH 
loop of VP1 . A Cot trace for a single copy of VP1 (blue) , VP2 (green) 
and VP3 (red) of monolayer·cell·adapted A22 FMDV is shown. The 
C terminus of VP1 from a fivefold·related protomer is depicted in cyan. 
The conformation of the GH loop in Dn·treated 01BFS FMDV is 
depicted in yellow. Space filling models of side·chain atoms indicate 
the positions of residues which affect the structure of the GH loop of 
VP1: in VP1, 43, 48, 59 (see [41]); in VP2, 80 (see [27]) and 82 and 
88 [141; in VP3 residues 175-183 (this work). The residue labels are 
colour·coded as for the proteins. 
antigenic variation: as well as permitting a high degree of 
sequence variability, it seems to facilitate structural 'cross-
talk' with other regions of the capsid surface. 
In spite of these advantages , long flexible loops are 
observed infrequently in nature. A potential disadvantage 
of the greater flexibility displayed by FM DV is suscepti-
bility to proteolysis. Thus, in poliovirus, for example, all of 
the surface loops were resolved in the crystal structures 
[7,8] although even here there is evidence for structural 
cross-talk involving an antigenic site [8]. This increased 
rigidity may be linked to the fact that poliovirus, unlike 
FMDV, must endure passage through the gut in order to 
replicate; however, there may also be a further reason. 
Interaction of poliovirus with its cellular receptor leads to 
a concerted conformational change in the virus capsid as a 
pre-requisite to uncoating. The mechanics of biological 
function thereby require some rigidity to drive the 
transition, whereas in FMDV acidification is sufficient to 
initiate uncoating. 
Structure of a suspension-ceil-adapted variant 
Although some viruses, such as human rhinovirus (HRV), 
appear to have successfully separated determinants of cell 
tropism from important antigenic sites [6], features which 
are necessarily located on the external surfaces of viral pro-
teins, others sustain a closer physical association of these 
functions. Interdependence of the two functions inevitably 
results. The V3 domain of the gp120 glycoprotein in HIV, 
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for example, is a key determinant of cell tropism [40-42] 
and is the site of a proteolytic cleavage thought to be 
required for infection [43-45]. The same domain has been 
identified as an important antigenic and immunogenic 
feature of HIV [46,47]. Similarly, in FMOV the conserved 
Arg-Gly-Asp receptor-binding motif of the GH loop of 
VP1 [21,24,25] is flanked on both sides by hypervariable 
sequences that constitute the most intensively studied 
antigenic sites on the viral capsid [34-36,48]. Conse-
quently, adaptation of FMOV to different growth condi-
tions often leads to sequence and· antigenic variation 
[20,49]. Sequence changes have most often been observed 
in the GH loop of VP1 itself. However, adaptation of the 
monolayer-cell-adapted stock of FMOV A22 to suspen-
sion-cell culture resulted in a variant containing three 
amino-acid changes in VP2 [14]. The variant bound to 
both monolayer and suspension cells better than the 
monolayer-adapted parental strain but had a small plaque 
phenotype and displayed a tendency to aggregate [14]. 
Moreover, although antisera raised with the monolayer-
adapted virus neutralized a wide range of field strains of 
serotype A FMOV, antisera raised using the variant was 
much less effective against heterologous viruses although 
it was a potent immunogen for homotypic responses (the 
suspension virus always induced higher levels of antibody) 
[14,30,31]. Curiously, however, monoclonal antibodies 
produced against the monolayer-cell-adapted virus, most 
of which recognised the GH loop of VPl, generally had 
higher neutralization titres against the variant [14]. On the 
basis of the structure of a type ° virus, which shares 70% 
amino-acid-sequence homology with type A FMOV, it 
was suggested that the two mutations located on the 
exterior of VP2 (Glu82~Gly and Lys88~Thr) would be 
principal determinants of the altered antigenic and cell-
binding properties of the variant [31] and would act by 
influencing the structure of the GH loop ofVPl. 
The structure of suspension-cell-adapted FMOV A22 
presented here contains only two of the three mutations 
reported [14] and only one of the two found on the exte-
rior surface of VP2 (Fig. 3). Nevertheless, it appears to 
share the same phenotype as the virus isolated by Bolwell 
and colleagues [14]. The surface mutation (Glu82~Gly) 
is located close to the GH loop of VPl and therefore 
appears to be key to the phenotype of the suspension-
cell-adapted variant (Fig. 5). In OTT-treated serotype ° 
virus, where the loop adopts a stable conformation [33] , 
Glu82 (which is conserved between ° and A type FMOV) 
makes three hydrogen bonds with the GH loop. Although 
in the parental monolayer-cell-adapted A22 FMOV the 
GH loop is largely disordered, it shares some similarity 
with the OTT-treated 01BFS loop structure and appears 
to lie predominantly over VP2. The loss of the glutamate 
side chain in the suspension-cell-adapted variant of A22 
has relatively little observable impact on the structure of 
the GH loop of VPl. The visible N-terminal end 
(residues 130-137) appears somewhat more stable (Fig. 4) 
and there is evidence of greater interaction with the 
surface of VP2. This is surprising given the evident stabi-
lizing effect of Glu82 in OTT-treated 01 BFS. The C-ter-
minal portion of the loop is less stable. It seems likely that 
mutations on the surface of VP2 alter the balance of forces 
on the GH loop so that a different ensemble of conforma-
tions is favoured. 
Although the nature of the differences in the receptors 
for FMOV between monolayer and suspension BHK-21 
cells is unknown, it is likely that the suspension cells 
display a different array of integrins. The suspension-
cell-adapted variant binds better to both cell types, sug-
gesting that either this virus can recognize a different, 
higher titre, receptor present on both cell lines, or, alter-
natively, the parent virus is unable to bind to the receptor 
used on suspension cells, restricting it to an integrin on 
the monolayer cells. 
The subtle structural changes between monolayer- and 
suspension-cell-adapted A22 FMOVs confer distinct 
antigenic properties. Access to residue 82 of VP2 is likely 
to be obscured by the overlying GH loop of VPl; the 
main antigenic differences therefore appear to be attrib-
utable to the changes induced in the VPl GH loop of the 
variant. (Glu82 is relatively buried in the structure having 
a fractional accessibility of 0.23 calculated using 
QUANTA [Molecular Simulations] compared with 0.86 
for Glu131 of VP2 and 0.83 for Glu59 of VP3, which are 
both located at antigenic sites.) This is supported by the 
observation that monoclonal antibodies (mAbs) raised 
against the parent bind the variant at least as tightly, 
arguing against a specific interaction between the gluta-
mate and the mAbs [14]. Antibqdies are exquisitely 
sensitive to structural variation, a simple side-chain dif-
ference often being sufficient to greatly impair binding 
[4,28]. In the worst case a single substitution can result in 
an ineffective vaccine [18]. This, together with the disor-
der in the GH loop of VP1, makes it difficult to con-
clusively demonstrate the mechanism underlying the 
puzzling antigenic properties of these viruses [14,31], 
although the greater apparent stability of the VP1 GH 
loop in the suspension-cell-adapted variant suggests a 
possible explanation. Thus, monoclonal antibodies raised 
against the monolayer-cell-adapted virus (parent) and 
which bind to the GH loop of VP1 are generally more 
effective against the variant than against the parent [14]. 
This is consistent with greater stability of part of the VP1 
GH loop in the variant which reduces the entropic cost of 
antibody binding. Conversely, antiserum raised by the 
variant neutralizes the variant with a titre 12- to SO-fold 
higher than it does the parent [14,39]. Again, entropy 
may provide at least a partial explanation, the greater 
flexibility of the GH loop in the parent viruses increasing 
the entropic cost of binding. 
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Biological implications 
Antigenic variation between the seven serotypes 
of the picornavirus foot-and-mouth disease virus 
(F:YIDV) poses difficulties in controlling the 
disease by vaccination. Moreover, tissue-culture 
adaptation of viruses, which is frequently required 
for large-scale vaccine production, can give rise to 
further antigenic variation which may compromise 
nlccine effectiveness. Picornaviruses comprise four 
capsid proteins, VPl-4. The interdependence of anti 
genicity and host-cell specificity arises in FMDV 
hecause a single extended loop on the viral surface 
- the GH loop of VPl - not only contains the 
Arg-Gly-Asp motif required for receptor binding 
hut also comprises an important antigenic site. In 
the case of a type A22 FMDV, merely adapting the 
virus from monolayer- to suspension-BHK cell 
culture resulted in a variant that displayed differ-
ences in cell-binding properties and antigenicity as a 
consequence of three amino-acid substitutions in the 
capsid protein VP2. However, these differences 
arose because of mutations outside the VPl GH 
loop suggesting that interactions between the loop 
and other parts of the viral capsid could affect its 
structure and function. 
Comparison of monolayer- and suspension-cell-
adapted A22 FMDVs shows that a single mutation 
(Glu82~Gly) on the surface of VP2 in the suspen-
sion-ceIl-adapted virus appears to perturb the struc-
ture of the VPl GH loop causing stabilization at the 
:"oi-terminal and destabilization at the C-terminal por-
tions of the loop. This appears to be the principal 
determinant of the differences in the variant's 
host-cell interactions and antigenicity. 
These "iruses belong to the third FMDV serotype 
(A) to be structurally characterized and our results 
reveal significant differences in the surface structure 
of each serotype. In common with type 0 and C 
FMDVs, the GH loop of VPl of a type A virus is 
very flexible and the largest differences between 
serotypes are associated with this loop. The flexibility 
of the VPl GH loop allows considerable sequence 
and antigenic variation around the conserved recep-
tor-binding motif. We have found that this loop flexi-
bility may also be exploited to amplify the structural 
effects of sequence changes. In addition to the case 
mentioned above, comparison of the structures of 
A22 with type 0 FMDV indicated that the confor-
mation of the GH loop of VPl profoundly affects the 
structure adopted by the GH loop of VP3 in an 
adjoining protomer; this extends the impact of 
sequence and structural variation in the VPl GH 
loop even though the VP3 GH loop sequences in the 
two viruses are identical. 
Materials and methods 
Virus growth, purification and crystallization 
The monolayer-cell-adapted clone of FMDV A22 Iraq 24/64 
(162-154) and the suspension-cell-adapted clone (148-173) [14] 
were kindly supplied by Dr EJ Ouldridge. The suspension-cell-adapted 
(variant) virus was grown in roller bottles of BHK-21 monolayers as it 
is known to propagate in monolayers as efficiently as the parental virus 
[14]. The propagation, purification and crystallization of the monolayer-
cell-adapted (parental) virus has been described [50]. Because of the 
tendency of the variant to aggregate during purification, a modification 
of the purification procedure was developed. Briefly, upon attaining 
full cytopathic effect the infected cells were lysed with 40 mM Tris, 
300 mM NaCI, pH 7.6 (buffer A) containing 0.1% (v/v) Triton X-lOO. 
Virus precipitated with (NH4)2S04 was resuspended in buffer A con-
taining 0.1 % (v/v) Triton X-lOO. Material that was not resuspended 
was removed by centrifugation and the virus pelleted through a 
cushion of 30% (w/v) sucrose in buffer A at 141 000 x g, 4°C for 150 
min. The virus pellets were soaked overnight in buffer A and then 
treated with 0.1 mg ml-1 RNase and 0.2% (v/v) Triton X-l00 before 
ultracentrifugation through 15-45% (w/v) sucrose gradients contain-
ing 2.5 M NH4CI, 40 mM T ris, pH 7.6 at 141 000 x g, 12°C, for 3.5 h. 
Fractions containing virus were pooled and diluted with an equal 
volume of 2.5 M NH4CI, 40 mM Tris, pH 7.6 and the virus pelleted 
finally at 275 OOOxg for 3 h at 12°C, through 30% (w/v) sucrose con-
taining the same buffer. The virus was resuspended at a concentration 
of 10 mg ml-1 in 1.0 M NH4CI, 40 mM Tris, 3 mM NaN3, pH 7.6 and 
stored at 4°C. 
Crystals of the suspension-cell-adapted variant were obtained by 
sitting drop vapour diffusion in microbridges [51]. Typically 5 J.LI of 
10 mg ml-1 virus was mixed with 5 ,..d from the reservoir. The virus crys-
tallized in 3.8-4.5% (w/v) polyethylene glycol (PEG) 20000 containing 
2.5 M NH4CI, 4% (v/v) l,4-dioxane, 0.1 M sodium phosphate, pH 7.6 
at 21°C. Very similar conditions, but with 4 M rather than 2.5 M NH4CI 
and lacking l,4-dioxane, were used to crystallize the parent virus and 
empty capsids [50]. Crystal yields and sizes were improved by micro-
and macroseeding [52]. Three crystal habits were observed under our 
crystallization conditions: Type I, truncated triangular prisms; Type II, 
hexagonal prisms with scooped patterns on the hexagonal faces; Type 
III, irregular pentagonal prisms, which appeared to be truncated ver-
sions of type II that lacked their surface 'scoops'. All of the variant 
habits differed from those observed with parental virus. Types I and II 
gave disordered diffraction; Type III crystals diffracted to 2.4 A resolu-
tion and were used for data collection. They were found to have the 
same space group (1222) and cell dimensions as the parental virus 
crystals (see below). 
Data collection and processing 
X-ray data collection for parental virus, performed at the SERC Syn-
chrotron Radiation Source, Daresbury, UK, has been described [50]. 
For crystals of the A22 suspension-cell-adapted variant the data were 
also collected at Daresbury using similar protocols. In this case 
however, the data were recorded on the Rigaku R-Axis II imaging plate 
device installed on station 9.6. Diffraction data for the parental virus 
were collected on CEA X-ray film and on a Marresearch Hendrix-
Lentfer imaging plate device on stations 9.6 and 9.5. Both imaging 
devices enabled multiple exposures (5-35) from each crystal in con-
trast to film with which a maximum of 2 exposures per crystal were 
obtained. Film data were processed as described previously [53]. 
Image plate data were processed using MOSFILM (A Leslie, unpub-
lished program). The data were merged and scaled using ROTAVATA 
and AGROVATA and post refined with POSTREF, all programs from 
the CCP4 package [54]. Reflections which were more than 70% 
recorded were scaled appropriately and treated as fully recorded. 
Rmerge values for the parent and variant data were 1 7.7% and 9.6%, 
respectively (Table 1). The low Rmerge of the variant data reflects the 
fact that they were collected from a single well-diffracting crystal and 
also the much lower redundancy in the data. 
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Figure 6 
Typical electron density from the 2Fo-Fe map for monolayer-cell-
adapted A22 FMDV calculated with phases refined by cyclic 15-fold 
non-crystallographic averaging_ The portion shown includes the DE 
and HI loops which are exposed on the surface of VPl close to the 
fivefold symmetry axis at the centre of a pentamer. 
Structure determination of the monolayer-cell-adapted virus 
A self-rotation function was calculated for the parental A22 FMDV data 
using POLARRFN from the CCP4 package in order to resolve the 
ambiguity in the orientation of the icosahedral virion in the 1222 unit 
cell_ With this information, a model of 01BFS FMDV was placed at 
position 0,0,0 and used in a rigid body grid search with X-PLOR [55] 
to refine the cell dimensions. These were found to be a=328.2 A, 
b=341 .2 A and c=363.7 A. 
Initial phases were calculated by placing an unrefined model of A 1 0SI 
FMDV (Fry et al_, unpublished data) in the unit cell. 2F obs -F cale and 
Fobs -F eale maps were calculated using these phases and put through 
one cycle of 15-fold noncrystallographic averaging using an early 
version of GAP (J Grimes and DS, unpublished program). The result-
ing map was of high quality: the amino acid differences between 
A 1 0SI and A22 Iraq FMDV were very evident indicating a lack of bias 
towards the A 1 0SI model. An initial model for the parental A22 virus 
was built into this map using FRODO [56] and refined with X-PLOR. 
The model used in the refinement contained a bulk solvent correction 
calculated with solrad= 0.1 A, ksolv=0.35 and Bsolv=50 A2, values 
which were determined to be optimal for the A22 data set. Through-
out refinement strict noncrystallographic symmetry constraints and 
the parameter set of Engh and Huber [57] were used . Phases calcu-
lated from the refined model were refined by a further cycle of non-
crystallographic symmetry averaging. A second round of model 
building and refinement followed. At this point a 2Fobs-Feale map cal-
culated using model phases was averaged to convergence with GAP. 
The final correlation coefficient, C AV ' for this map was 0.967 and RAV 
was 21 .9% (Table 1; Fig. 6) . Using the phases refined by averaging, 
2Fobs-Feale and Fobs-Feale maps were calculated in order to make 
minor adjustments to the model before final positional and B-factor 
refinement with X-PLOR. Subsequently, 310 water molecules have 
been added and the final refinement statistics are given in Table 1. 
The model lacks residues 137-155 and 211 of VP1 , 1-11 of VP2 
and 1-14 and 40-64 of VP4. 
Structure determination of the suspension-cell-adapted virus 
For the variant, 2Fova'-FoP"' and Fova'-F/ "' maps were calculated using 
the parental phases from the cyclic averaging; FoP", and Fova, are the 
observed structure factors . for the parent and variant respectively. 
These maps were then subjected to a single cycle of noncrystallo-
graphic symmetry averaging. The model of the monolayer-cell-adapted 
A22 FMDV was used as a starting point for model building. The model 
was subjected to positional and B-factor refinement with X-PLOR. 
2F 0 -Fe and F 0 -Fe maps calculated with model phases were used to 
make adjustments to the model and to add 243 water molecules 
before final positional and B-factor refinement (Table 1). The variant 
model lacks residues 138-156 and 211 of VP1 , 1-11 of VP2 and 
1-14 and 40-64 of VP4. 
Molecular graphics 
Model building was performed using FRO DO [56] . Figures were 
prepared with 0 [58] and Photoshop (Adobe) . 
cDNA sequencing 
Single-stranded cDNA was synthesized from purified viral RNA using 
reverse transcriptase and oligo A22F (5'-CTGGTIGCCAACAGCGGA-
3'; VP2 nucleotides 600-583) . The VP2 coding sequence containing 
codons for two of the mutations in the variant was amplified using oligos 
A22F and A22R (5'-CAGGCAGAAAGATTI-TIC-3'; VP2 nucleotides 
441-424) in the polymerase chain reaction and cloned in to the vector 
pGEMt (Promega) . Three independent amplifications were sequenced 
in both directions. 
Coordinates have been deposited with the Brookhaven Protein Data 
Bank. 
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